EA201301080A1 - Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания - Google Patents

Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания

Info

Publication number
EA201301080A1
EA201301080A1 EA201301080A EA201301080A EA201301080A1 EA 201301080 A1 EA201301080 A1 EA 201301080A1 EA 201301080 A EA201301080 A EA 201301080A EA 201301080 A EA201301080 A EA 201301080A EA 201301080 A1 EA201301080 A1 EA 201301080A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dimethylpropan
carboxy
ethyl
treatment
cardiovascular disease
Prior art date
Application number
EA201301080A
Other languages
English (en)
Other versions
EA023547B1 (ru
Inventor
Иварс Калвиньш
Эдгарс Лепиньш
Эйнарс Лоза
Мая Дамброва
Илмарс Стонанс
Дайна Лола
Янис Кука
Освальд Пугович
Райнис Вилскертц
Сольвейга Гринберга
Original Assignee
Гриндекс, Джоинт Сток Кампани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гриндекс, Джоинт Сток Кампани filed Critical Гриндекс, Джоинт Сток Кампани
Publication of EA201301080A1 publication Critical patent/EA201301080A1/ru
Publication of EA023547B1 publication Critical patent/EA023547B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/04Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • C07C225/06Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and acyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/10Succinic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Соли 3-карбокси-N-этил-N,N-диметилпропан-1-аммония, способ их получения и применение при лечении сердечно-сосудистого заболевания.
EA201301080A 2011-04-27 2012-04-27 Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания EA023547B1 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP11163839 2011-04-27
EP11163872 2011-04-27
EP11163841 2011-04-27
EP11163871 2011-04-27
EP11163840 2011-04-27
PCT/EP2012/057806 WO2012146736A1 (en) 2011-04-27 2012-04-27 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease

Publications (2)

Publication Number Publication Date
EA201301080A1 true EA201301080A1 (ru) 2014-02-28
EA023547B1 EA023547B1 (ru) 2016-06-30

Family

ID=46062261

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201301080A EA023547B1 (ru) 2011-04-27 2012-04-27 Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания

Country Status (25)

Country Link
US (2) US20140088125A1 (ru)
EP (1) EP2702033B1 (ru)
JP (1) JP5997762B2 (ru)
KR (1) KR20130138827A (ru)
CN (1) CN103608326B (ru)
AU (1) AU2012247467B2 (ru)
BR (1) BR112013027065B1 (ru)
CA (1) CA2832693C (ru)
CY (1) CY1117890T1 (ru)
DK (1) DK2702033T3 (ru)
EA (1) EA023547B1 (ru)
ES (1) ES2585558T3 (ru)
GE (1) GEP20156373B (ru)
HR (1) HRP20160998T1 (ru)
HU (1) HUE030415T2 (ru)
IL (1) IL228891A (ru)
LT (1) LT2702033T (ru)
MX (1) MX351765B (ru)
PE (1) PE20140777A1 (ru)
PL (1) PL2702033T3 (ru)
PT (1) PT2702033T (ru)
RS (1) RS55092B1 (ru)
SI (1) SI2702033T1 (ru)
SM (1) SMT201600416B (ru)
WO (1) WO2012146736A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3117B1 (ar) * 2012-12-20 2017-09-20 Grindeks Jsc استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين
JO3333B1 (ar) * 2013-09-26 2019-03-13 Grindeks Jsc استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1103259A (en) * 1913-04-23 1914-07-14 John J Buckley Fly-paper holder.
GB1238868A (ru) 1967-08-08 1971-07-14
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
US5973026A (en) 1998-02-02 1999-10-26 Xerox Corporation Ink jet inks
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
CA2535150C (en) * 2003-08-04 2010-04-13 Joint Stock Company "Grindeks" Non-hygroscopic, stable meldonium salts, method of preparation and pharmaceutical compositions thereof
CA2508094A1 (en) 2005-05-20 2006-11-20 Vivier Canada Inc. Composition for accelerating collagen synthesis
US7863274B2 (en) 2005-07-29 2011-01-04 Concert Pharmaceuticals Inc. Deuterium enriched analogues of tadalafil as PDE5 inhibitors
LV13705B (en) 2006-11-06 2008-07-20 Ivars Kalvins Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide
JP4761265B2 (ja) 2007-10-17 2011-08-31 学校法人甲南学園 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法
TWI391131B (zh) * 2007-12-05 2013-04-01 Grindeks Jsc 3-(2,2,2-三甲基肼)丙酸鹽的新用途
ATE527996T1 (de) * 2007-12-12 2011-10-15 Grindeks Jsc Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat
WO2010149654A1 (en) * 2009-06-25 2010-12-29 Grindeks, A Joint Stock Company Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
BRPI1009600A2 (ru) * 2009-06-25 2016-03-22 Tetra S A
LV14345B (lv) * 2009-10-22 2011-07-20 Grindeks, A/S 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai

Also Published As

Publication number Publication date
AU2012247467A1 (en) 2013-11-14
SMT201600416B (it) 2017-01-10
CN103608326A (zh) 2014-02-26
US10351534B2 (en) 2019-07-16
LT2702033T (lt) 2016-09-12
DK2702033T3 (en) 2016-08-29
RS55092B1 (sr) 2016-12-30
CN103608326B (zh) 2016-01-20
CY1117890T1 (el) 2017-05-17
CA2832693A1 (en) 2012-11-01
WO2012146736A8 (en) 2013-03-28
WO2012146736A4 (en) 2013-01-31
PT2702033T (pt) 2016-08-17
US20140088125A1 (en) 2014-03-27
US20180079728A1 (en) 2018-03-22
BR112013027065A2 (pt) 2016-12-27
IL228891A0 (en) 2013-12-31
EP2702033A1 (en) 2014-03-05
EA023547B1 (ru) 2016-06-30
MX351765B (es) 2017-10-26
AU2012247467B2 (en) 2016-07-28
MX2013012551A (es) 2015-04-10
HUE030415T2 (en) 2017-05-29
IL228891A (en) 2015-11-30
BR112013027065B1 (pt) 2019-12-03
CA2832693C (en) 2018-10-02
PL2702033T3 (pl) 2017-04-28
JP2014523403A (ja) 2014-09-11
JP5997762B2 (ja) 2016-09-28
GEP20156373B (en) 2015-09-25
PE20140777A1 (es) 2014-07-20
HRP20160998T1 (hr) 2016-10-21
NZ616467A (en) 2015-10-30
KR20130138827A (ko) 2013-12-19
EP2702033B1 (en) 2016-06-08
SI2702033T1 (sl) 2016-09-30
WO2012146736A1 (en) 2012-11-01
ES2585558T3 (es) 2016-10-06

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
EA201400178A1 (ru) Лечение рака молочной железы
BR112013032229A2 (pt) método de tratamento hidrocatalítico hidrotérmico de biomassa, e, composição
EA201400579A1 (ru) Антитела к il-36r
EA201492040A1 (ru) Бициклически замещённые урацилы и их применение
EA201290988A1 (ru) Стереоселективный синтез фосфорсодержащих активных соединений
EA201500314A1 (ru) Лекарственные формы энзалутамида
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
CL2012003385A1 (es) Tratamiento para la incontinencia.
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
BR112013033811A2 (pt) composição, método de preparação da composição, e, composto
EA201201357A1 (ru) Антитела к cd40
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
AR090903A1 (es) Anticuerpos e inmunoconjugados anti-pmel17
BR112013023277A2 (pt) métodos de tratamento de câncer usando 3-(5-amino-2-metil-4-oxo-4h-quinazolin-3-il)-piperidibna-2,6-diona
EA201490559A1 (ru) Композиция для лечения свища
BR112014004192A2 (pt) composição de tratamento de sementes, e, método de tratamento de sementes
EA201491303A1 (ru) Конденсированные тетра- или пентациклические дигидродиазепинокарбазолоны в качестве ингибиторов parps
EA201591024A1 (ru) Димерные соединения
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
UY34070A (es) Método y composición para tratamiento de semillas.
BR112013021775A2 (pt) bactéria corineforme, e, método para produzir um l-aminoácido
FR2979346B1 (fr) Nanocorps anti-vcam-1
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.